BCHE and Alzheimer disease: Treatment with cholinesterase inhibitors has proven effective in improving global cognitive function, the activities of daily living, and behavioral symptoms in patients with mild to moderate AD (Raskind et al., 2000; Tariot et al., 2000; Rockwood et al., 2006).